Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
MDA-MB-361
HER2amp
Luminal
PD184352
MEK
MAPK
10999.155
uM
inf
inf
0.9030 0.9030 0.0000 -0.0123
-0.1189
0.7370
LY2
HR+
Luminal
Nilotinib
ABL
nRTK
10816.145
uM
inf
inf
1.0500 1.0500 0.0000 -0.0123
-0.0004
0.7766
MDA-MB-361
HER2amp
Luminal
PD184352
MEK
MAPK
10999.155
uM
inf
inf
0.9030 0.9030 0.0000 -0.0123
-0.1189
0.7370
BT-549
TNBC
Basal B
Methotrexate
DHFR
Metabolism
5910.084
uM
inf
inf
0.9374 0.9374 0.0000 -0.0121
0.4733
3.1096
BT-474
HER2amp
Luminal
TCS PIM-1 1
Pim kinase
PIM
12178.135
uM
inf
inf
0.9217 0.9217 0.0000 -0.0119
0.2808
0.5524
SUM225CWN
HER2amp
Basal A
SB-3CT
MMP2/9
MMP
10579.144
uM
inf
inf
0.8597 0.8597 0.0000 -0.0118
0.3052
0.9576
Hs 578T
TNBC
Basal B
Triciribine
AKT
AKT
7474.074
uM
inf
3.54150
0.8416 0.8448 4.9283 -0.0117
0.7209
2.6218
ZR75B
HR+
Luminal
Trastuzumab
HER2
ErbB
9997.026
uM
10.14060
9.03470
0.8100 0.2193 4.9983 -0.0116
0.7236
1.1348
Hs 578T
TNBC
Basal B
Sirolimus
MTOR
MTOR
7474.069
uM
inf
inf
1.0500 1.0500 0.0000 -0.0115
-0.0565
2.5606
Hs 578T
TNBC
Basal B
GSK1838705A
IGF1R
RTK
7473.098
uM
inf
inf
0.7393 0.7393 0.0000 -0.0112
0.2240
2.2810
MCF12A
NM
Basal B
FTase Inhibitor I
Ftase
MAPK
10817.154
uM
inf
inf
1.0326 1.0326 0.0000 -0.0111
-0.1985
1.4551
LY2
HR+
Luminal
SB-3CT
MMP2/9
MMP
10816.144
uM
inf
inf
0.9453 0.9453 0.0000 -0.0111
-0.0185
0.9146
Hs 578T
TNBC
Basal B
Sorafenib
PDGFR/VEGFR/KIT/FLT3
RTK
7473.084
uM
1210.01560
999.18010
0.6509 0.3033 4.8722 -0.0111
0.8989
2.0337
MCF 10A
NM
Basal B
Trastuzumab
HER2
ErbB
9551.026
uM
inf
inf
0.9124 0.9124 0.0000 -0.0111
0.4645
2.6508
ZR-75-1
HR+
Luminal
Cetuximab
EGFR
ErbB
7931.042
uM
inf
inf
0.8278 0.8278 0.0000 -0.0111
0.4074
1.3878
T47DKBLUC
Unknown
Unknown
Erlotinib
EGFR
ErbB
7545.092
uM
inf
inf
0.9211 0.9211 0.0000 -0.0109
0.4842
0.9794
AU565
HER2amp
Luminal
Selumetinib
MEK
MAPK
10880.155
uM
inf
inf
1.0500 1.0500 0.0000 -0.0108
-0.1312
1.5205
MCF12A
NM
Basal B
Trastuzumab
HER2
ErbB
10061.123
uM
17.14380
8.78160
0.8599 0.4824 4.9997 -0.0107
0.7497
1.9064
MDA-MB-453
TNBC
Luminal
Cisplatin
DNA cross-linker
DNA cross-linker
9723.049
uM
inf
inf
1.0150 1.0150 0.0000 -0.0107
-0.0715
0.9525
MDA-MB-361
HER2amp
Luminal
TPCA-1
IKK
NFKB
7506.093
uM
inf
inf
0.7940 0.7940 0.0000 -0.0107
0.1828
0.9162
HCC3153
TNBC
Basal A
FR180204
ERK1/2
MAPK
10577.137
uM
inf
inf
0.9341 0.9341 0.0000 -0.0104
0.0824
0.9653
MCF 10F
NM
-
(Z)-4-Hydroxytamoxifen
ESR1
7871.016
uM
inf
34.66260
0.8429 0.8429 4.9988 -0.0104
0.6376
1.0272
HCC3153
TNBC
Basal A
Pemetrexed
TYMS/DHFR/GARFT
TYMS
7466.095
uM
inf
inf
1.0039 1.0039 0.0000 -0.0104
-0.0877
0.8699
HCC1395
TNBC
Basal B
Cetuximab
EGFR
ErbB
7816.042
uM
inf
inf
1.0005 1.0005 0.0000 -0.0101
-0.0006
0.9332
Hs 578T
TNBC
Basal B
Dichloroacetate
PDK
PDK
12622.176
uM
inf
inf
0.9947 0.9947 0.0000 -0.0101
-0.9347
2.5005